These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7702674)

  • 1. [A petrifactive lesion. Fibrodysplasia ossificans progressiva (FOP)].
    De Montpréville VT; Nashashibi N; Dulmet E
    Ann Pathol; 1995; 15(1):71-2. PubMed ID: 7702674
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrodysplasia ossificans progressiva (FOP).
    Paim LB; Liphaus Bde L; Almeida da Silva CA
    Indian Pediatr; 2003 Aug; 40(8):786-8. PubMed ID: 12951384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrodysplasia ossificans progressiva (FOP).
    Kaplan FS; Smith RM
    J Bone Miner Res; 1997 May; 12(5):855. PubMed ID: 9144353
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva.
    Gannon FH; Valentine BA; Shore EM; Zasloff MA; Kaplan FS
    Clin Orthop Relat Res; 1998 Jan; (346):19-25. PubMed ID: 9577406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of the gene for fibrodysplasia ossificans progressiva (FOP) to chromosome 17q21-22.
    Lucotte G; Bathelier C; Mercier G; Gérard N; Lenoir G; Sémonin O; Fontaine K;
    Genet Couns; 2000; 11(4):329-34. PubMed ID: 11140409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell involvement in fibrodysplasia ossificans progressiva.
    Gannon FH; Glaser D; Caron R; Thompson LD; Shore EM; Kaplan FS
    Hum Pathol; 2001 Aug; 32(8):842-8. PubMed ID: 11521229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catastrophic falls in patients who have fibrodysplasia ossificans progressiva.
    Glaser DL; Rocke DM; Kaplan FS
    Clin Orthop Relat Res; 1998 Jan; (346):110-6. PubMed ID: 9577417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lumbar puncture and surgical intervention in a child with undiagnosed fibrodysplasia ossificans progressiva.
    Zaghloul KA; Heuer GG; Guttenberg MD; Shore EM; Kaplan FS; Storm PB
    J Neurosurg Pediatr; 2008 Jan; 1(1):91-4. PubMed ID: 18352811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic overexpression of the c-Fos protooncogene. A murine stem cell chimera applicable to the study of fibrodysplasia ossificans progressiva in humans.
    Olmsted EA; Gannon FH; Wang ZQ; Grigoriadis AE; Wagner EF; Zasloff MA; Shore EM; Kaplan FS
    Clin Orthop Relat Res; 1998 Jan; (346):81-94. PubMed ID: 9577414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human leukocyte antigen B27 allele is not correlated with fibrodysplasia ossificans progressiva.
    Calvert GT; Shore EM
    Clin Orthop Relat Res; 1998 Jan; (346):66-70. PubMed ID: 9577412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stone man: fibrodysplasia ossificans progressiva.
    Taylor JS
    Ala Med; 1984 Oct; 54(4):24, 26-7. PubMed ID: 6507229
    [No Abstract]   [Full Text] [Related]  

  • 12. A new mutation of the noggin gene in a French Fibrodysplasia ossificans progressiva (FOP) family.
    Fontaine K; Sémonin O; Legarde JP; Lenoir G; Lucotte G
    Genet Couns; 2005; 16(2):149-54. PubMed ID: 16080294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle imaging in fibrodysplasia ossificans progressiva: The neurologist's perspective.
    Tasca G; D'Amico A; Verardo M; Villani A; Siani P; De Brasi D; Bertini E; Boldrini R
    Neuromuscul Disord; 2015 Aug; 25(8):672-3. PubMed ID: 26077615
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary basic fibroblast growth factor. A biochemical marker for preosseous fibroproliferative lesions in patients with fibrodysplasia ossificans progressiva.
    Kaplan F; Sawyer J; Connors S; Keough K; Shore E; Gannon F; Glaser D; Rocke D; Zasloff M; Folkman J
    Clin Orthop Relat Res; 1998 Jan; (346):59-65. PubMed ID: 9577411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histochemical and ultrastructural studies in fibrodysplasia ossificans progressiva (myositis ossificans progressiva).
    Maxwell WA; Spicer SS; Miller RL; Halushka PV; Westphal MC; Setser ME
    Am J Pathol; 1977 Jun; 87(3):483-98. PubMed ID: 141214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva.
    Ahn J; Feldman G; Terry L; Shore EM; Kaplan FS
    Clin Orthop Relat Res; 2003 Jan; (406):205-13. PubMed ID: 12579020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrodysplasia ossificans progressiva (FOP)].
    Saito K
    Ryoikibetsu Shokogun Shirizu; 2001; (33):714-5. PubMed ID: 11462649
    [No Abstract]   [Full Text] [Related]  

  • 18. Consideration of Rituximab for fibrodysplasia ossificans progressiva.
    Altschuler EL
    Med Hypotheses; 2004; 63(3):407-8. PubMed ID: 15288357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenous etidronate and oral corticosteroids in fibrodysplasia ossificans progressiva.
    Brantus JF; Meunier PJ
    Clin Orthop Relat Res; 1998 Jan; (346):117-20. PubMed ID: 9577418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrodysplasia ossificans progressiva. Report of two cases with ultrastructural study.
    Reichart PA; Barsekow F; Althoff J
    Int J Oral Surg; 1981; 10(Suppl 1):58-62. PubMed ID: 6807909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.